SHR-2554 / Jiangsu Hengrui Pharma, Treeline Biosci  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SHR-2554 / Treeline Biosci
NCT06122389: SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma

Recruiting
3
130
RoW
SHR2554; Chidamide analog tablets, SHR2554 analog tablets; Chidamide
Jiangsu HengRui Medicine Co., Ltd.
Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
05/26
07/26

Download Options